CALIMMUNE, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.calimmune.com
Clinical Trials
2
Active:1
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients
Active, not recruiting
- Conditions
- Receipt of Cal-1 Modified Hematopoietic Cellular ProductsHIV-1 Infection
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2025-10-10
- Lead Sponsor
- Calimmune, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT02390297
- Locations
- 🇺🇸
UCLA CARE Center, Los Angeles, California, United States
🇺🇸Quest Clinical Research, San Francisco, California, United States
Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection
Phase 1
Completed
- Conditions
- Human Immunodeficiency Virus
- Interventions
- First Posted Date
- 2012-11-28
- Last Posted Date
- 2020-08-06
- Lead Sponsor
- Calimmune, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT01734850
- Locations
- 🇺🇸
UCLA CARE Center, Los Angeles, California, United States
🇺🇸Quest Clinical Research, San Francisco, California, United States
News
No news found